Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-cell immunotherapy: looking forward.
Corrigan-Curay J, Kiem HP, Baltimore D, O'Reilly M, Brentjens RJ, Cooper L, Forman S, Gottschalk S, Greenberg P, Junghans R, Heslop H, Jensen M, Mackall C, June C, Press O, Powell D, Ribas A, Rosenberg S, Sadelain M, Till B, Patterson AP, Jambou RC, Rosenthal E, Gargiulo L, Montgomery M, Kohn DB. Corrigan-Curay J, et al. Among authors: heslop h. Mol Ther. 2014 Sep;22(9):1564-74. doi: 10.1038/mt.2014.148. Mol Ther. 2014. PMID: 25186558 Free PMC article. No abstract available.
Human gene marker/therapy clinical protocols.
Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, Walker RE, Schuening FG, Roth JA, Crystal RG, Welsh MJ, Culver K, Heslop HE, Simons J, Wilmott RW, Tiberghien P, et al. Rosenberg SA, et al. Among authors: heslop he. Hum Gene Ther. 1996 Dec 1;7(18):2287-313. doi: 10.1089/hum.1996.7.18-2287. Hum Gene Ther. 1996. PMID: 8953320 No abstract available.
Options for T-cell based therapies.
Heslop HE, Gottschalk SM, Bollard CM, Straathof KC, Huls MH, Brenner MK, Rooney CM. Heslop HE, et al. Vox Sang. 2004 Jul;87 Suppl 2:230-4. doi: 10.1111/j.1741-6892.2004.00494.x. Vox Sang. 2004. PMID: 15209923 Review. No abstract available.
Post-transplant lymphoproliferative disorders.
Gottschalk S, Rooney CM, Heslop HE. Gottschalk S, et al. Annu Rev Med. 2005;56:29-44. doi: 10.1146/annurev.med.56.082103.104727. Annu Rev Med. 2005. PMID: 15660500 Review.
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
Bollard CM, Huls MH, Buza E, Weiss H, Torrano V, Gresik MV, Chang J, Gee A, Gottschalk SM, Carrum G, Brenner MK, Rooney CM, Heslop HE. Bollard CM, et al. Among authors: heslop he. Clin Lymphoma Myeloma. 2006 Jan;6(4):342-7. doi: 10.3816/CLM.2006.n.011. Clin Lymphoma Myeloma. 2006. PMID: 16507214 Clinical Trial. No abstract available.
424 results